Help
Aids Top
Application: To test non-inferiority and superiority that unified by the following hypotheses:
Here δ is the non-inferiority (δ<0) or superiority margin (δ>0).
Procedure:
a) value of α, the probability of type I error
b) value of β, the probability of type II error
c)
value of θ, a true mean response rate of a test drug
d) value of θ0, a reference response rate
e) value of δ, the non-inferiority margin (δ<0) or superiority margin (δ>0).
Formula:
(*)
Notations:
α: The
probability of type I error (significance level) is the probability of rejecting the true null
hypothesis.
β: The
probability of type II error (1 – power of the test) is the probability of
failing to reject the false null hypothesis.
θ-θ0: The difference between the true mean response rates of a test drug (θ) and a reference value (θ0).
δ: Clinically meaningful difference. The largest change from the reference value (baseline) that is considered to be trivial.
Examples
Example 1:
We want to show that the majority of patients whose
change in bone density after treatment is at least as good as the reference
value, say, θ0=30%. If we
assume that a difference of 10% in responder rate is considered of no clinical
significance, say, δ=-10%, to test for non-inferiority. Also the true response rate is θ=50%. According to (*), at α=0.05,
the required sample size for having an 80% power (i.e., β=0.2) is N=18.
Reference: